[Hepatic transplantation and HBV reinfection].
Xu
Xiaogang
X
Department of Infectious Diseases, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, China.
Lu
Zhimeng
Z
D000998:Antiviral Agents / Q000627:therapeutic use*; D018890:Chemoprevention; D006509:Hepatitis B / Q000517:prevention & control*; D006526:Hepatitis C / Q000517:prevention & control*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D016031:Liver Transplantation / Q000473:pathology*; D012254:Ribavirin / Q000627:therapeutic use; D055502:Secondary Prevention
D000998:Antiviral Agents; D016898:Interferon-alpha; D019259:Lamivudine; D012254:Ribavirin